Jaguar Health (JAGX) FCF Payout Ratio (2021 - 2022)
Jaguar Health's (JAGX) quarterly FCF Payout Ratio came in at 0.02 in Q1 2022, down 209.3% year-on-year from 0.02 in Q1 2021, and down 209.3% on a QoQ basis from 0.01 in Q1 2021.
Jaguar Health (JAGX) FCF Payout Ratio (2021 - 2022) Analysis & Trends
Jaguar Health (JAGX) has 2 years of FCF Payout Ratio data on file, last reported at 0.02 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | - |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | - |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | 0.12 |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | - |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -0.02 |
| Mar 31, 2021 | -0.01 |